Sumitha C V, Pai Vijay, Thulasidas Mithun
Department of Ophthalmology, K.S Hegde Charitable Hospital, Deralakatte, Mangalore, Karnataka, India.
Centre for Sight Eye Institute, Plot No. 9, Sector 9, Dwarka, New Delhi, India.
Indian J Ophthalmol. 2020 Apr;68(4):597-602. doi: 10.4103/ijo.IJO_1043_19.
To evaluate the outcomes of implantation of an iris-claw intraocular lens (IC-IOL) in retropupillary position in aphakic patients.
We conducted a prospective interventional study, including 36 aphakic eyes with inadequate capsular support. The postoperative examination included best-corrected visual acuity (BCVA), intraocular pressure (IOP) measurement, central corneal thickness (CCT), and anterior segment examination with emphasis on the anterior chamber reaction and shape of pupil. Follow-up was done for 3 months.
Thirty-six eyes of 34 patients, including 22 right eyes and 14 left eyes were included. Indications for surgery were complicated cataract surgery in 38.9% (n = 14), aphakia in 27.8% (n = 10), pseudophakic bullous keratopathy in 16.7% (n = 6), dislocated posterior chamber IOL (PCIOL) in 11.1% (n = 4), IC drop in 2.8% (n = 1), and subluxated PCIOL in 2.8% (n = 1). Postoperatively, the visual acuity improved by at least two lines in 32 (88.9%) and worsened in four (11.1%) eyes at the end of three months. Mean postoperative IOP at the end of the third month was 12.42 mmHg (standard deviation [SD] 2.57; range 11.55-13.29 mmHg). The mean postoperative CCT at the end of the third month was 542.42 microns (SD 13.77; range 537.76-547.07 microns). Sixteen eyes (44.4%) had horizontally oval pupil, eleven eyes (30.6%) had round pupil, and nine eyes (25%) had irregular pupil. Twenty-three eyes (63.9%) presented with significant anterior chamber reaction and seven eyes (19.4%) had corneal stromal edema on postoperative day 1.
Our study demonstrated that retropupillary IC-IOL implantation in eyes without adequate capsular support is an effective and safe procedure with a good visual outcome and fewer complications.
评估无晶状体眼患者将虹膜爪型人工晶状体(IC-IOL)植入瞳孔后位的效果。
我们进行了一项前瞻性干预研究,纳入36只囊袋支撑不足的无晶状体眼。术后检查包括最佳矫正视力(BCVA)、眼压(IOP)测量、中央角膜厚度(CCT)以及前段检查,重点关注前房反应和瞳孔形态。随访3个月。
纳入34例患者的36只眼,其中右眼22只,左眼14只。手术指征包括复杂性白内障手术38.9%(n = 14)、无晶状体眼27.8%(n = 10)、人工晶状体性大泡性角膜病变16.7%(n = 6)、后房型人工晶状体(PCIOL)脱位11.1%(n = 4)、IC脱落2.8%(n = 1)、PCIOL半脱位2.8%(n = 1)。术后3个月末,32只眼(88.9%)视力至少提高两行,4只眼(11.1%)视力下降。术后第三个月末平均眼压为12.42 mmHg(标准差[SD]2.57;范围11.55 - 13.29 mmHg)。术后第三个月末平均中央角膜厚度为542.42微米(SD 13.77;范围537.76 - 547.07微米)。16只眼(44.4%)瞳孔呈水平椭圆形,11只眼(30.6%)瞳孔圆形,9只眼(25%)瞳孔不规则。术后第1天,23只眼(63.9%)出现明显前房反应,7只眼(19.4%)发生角膜基质水肿。
我们的研究表明,在囊袋支撑不足的眼中将IC-IOL植入瞳孔后位是一种有效且安全的手术,视觉效果良好,并发症较少。